Ying Liu

Ying Liu

Auto-generated profile, based on publicly available information

Ying Liu

National Laboratory for Poliomyelitis, WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2023 in Biosafety and Health
Verified
Journal Article
Open access
CWCongcong Wang
Congcong Wang
LJli jichen
li jichen
YLYing Liu
Ying Liu
QSQiang Sun
Qiang Sun
ZLZhijun Liu
Zhijun Liu
• Some enteroviruses cause central nervous system disease with clinical and pathological features. • Cellular receptors and host immune responses are required for enterovirus entry into the central nervous system. • The pathways and mechanisms by which viruses invade the central nervous system need to be better understood.

9 September 2023 in Biosafety and Health
Verified
Journal Article
Open access
YLYing Liu
Ying Liu
LJli jichen
li jichen
Yong ZhangYong Zhang
Yong Zhang
• Enteroviral protease 2A involves apoptosis, viral replication, and antiviral responses, implicating multiple pathways. • Enteroviral protease 2A could directly bind to crucial host factors and drive viral reproduction without cleavage. • Proteomics detection optimizes methodology in fragment identification and precise prediction on substrate cleavage sites . • Scattered variations on protease 2A imply the mechanism behind its structural changes requires further investigation.

6 September 2022 in Virus Evolution
Verified
Journal Article
Open access
PDF file
YLYing Liu
Ying Liu
ZHZhenzhi Han
Zhenzhi Han
CKChuyun Kang
Chuyun Kang
ACAili Cui
Aili Cui
YZYan Zhang
Yan Zhang
WXWenbo Xu
Wenbo Xu
To better understand the importation and circulation patterns of rubella virus lineages 1E-L2 and 2B-L2c circulating in China since 2018, 3,312 viral strains collected from 27 out of 31 provinces in China between 2018 and 2021 were sequenced and analyzed with the representative international strains of lineages 1E-L2 and 2B-L2c based on genotyping region. Time-scale phylogenetic analysis revealed that the global lineages 1E-L2 and 2B-L2c presented distinct evolutionary patterns. Lineage 1E-L2 circulated in relatively limited geographical areas (mainly Asia) and showed geographical and temporal clustering, while lineage 2B-L2c strains circulated widely throughout the world and exhibited a complicated topology with several independently evolved branches. Furthermore, both lineages showed extensive international transmission activities, and phylogeographic inference provided evidence that lineage 1E-L2 strains circulating in China possibly originated from Japan, while the source of lineage 2B-L2c isolated since 2018 is still unclear. After importation into China in 2018, the spread of lineage 1E-L2 presented a three-stage transmission pattern from southern to northern China, whereas lineage 2B-L2c spread from a single point in western China to all the other four regions. These two transmission patterns allowed both imported lineages to spread rapidly across China during the 2018–9 rubella epidemic and eventually established endemic circulations. This study provides critical scientific data for rubella control and elimination in China and worldwide.